Cargando…

CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation

INTRODUCTION: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) represents a standard treatment regime for multiple myeloma (MM) patients. Common and potentially fatal side effects after auto-HSCT are infections due to a severely compromised immune sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heck, Clarissa, Steiner, Sophie, Kaebisch, Eva M., Frentsch, Marco, Wittenbecher, Friedrich, Scheibenbogen, Carmen, Hanitsch, Leif G., Nogai, Axel, le Coutre, Philipp, Bullinger, Lars, Blau, Igor-Wolfgang, Na, Il-Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519398/ https://www.ncbi.nlm.nih.gov/pubmed/34659226 http://dx.doi.org/10.3389/fimmu.2021.736137

Ejemplares similares

Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach
por: Wittenbecher, Friedrich, et al.
Publicado: (2022)

Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
por: Obermayer, Benedikt, et al.
Publicado: (2023)

P828: EFFECT OF ANTI-CD38 MONOCLONAL ANTIBODIES ON THE INTERACTION OF MYELOMA CELLS WITH BONE MARROW STROMAL CELLS
por: Lienhart, Malgorzata, et al.
Publicado: (2023)

Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation
por: Mensen, Angela, et al.
Publicado: (2013)

Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination
por: Steiner, Sophie, et al.
Publicado: (2023)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias
por: Janjetovic, Snjezana, et al.
Publicado: (2021)

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region
por: Berenstein, Rimma, et al.
Publicado: (2015)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
por: Steiner, Sophie, et al.
Publicado: (2020)

Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation
por: Braune, Jan, et al.
Publicado: (2022)

Rabbit antithymocyte globulin induces rapid expansion of effector memory CD8 T cells without accelerating acute graft versus host disease()
por: Wittenbecher, Friedrich, et al.
Publicado: (2013)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
por: Grubovic, Rada M., et al.
Publicado: (2017)

Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade
por: Kofla, G., et al.
Publicado: (2022)

Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation
por: Hütter-Krönke, Marie Luise, et al.
Publicado: (2023)

Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival Outcome
por: Ciraolo, Elisa, et al.
Publicado: (2022)

Autologous Peripheral Blood Hematopoietic Cell Transplantation in Dogs with T‐Cell Lymphoma
por: Warry, E.E., et al.
Publicado: (2014)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
por: Orio, Francesco, et al.
Publicado: (2014)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN
por: Danner-Koptik, Karina E, et al.
Publicado: (2012)

SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Fernandes, Sandra, et al.
Publicado: (2015)

Herpes zoster after autologous hematopoietic stem cell transplantation
por: Santos, Kelli Borges dos, et al.
Publicado: (2016)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Optimizing autologous hematopoietic stem cell transplantation for acute leukemia
por: Pang, Aiming, et al.
Publicado: (2021)

Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
por: Orrantia, Ane, et al.
Publicado: (2021)

P1613: SINGLE-CELL ANALYSIS FOLLOWING SARS-COV-2 MRNA VACCINE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
por: Tranter, E., et al.
Publicado: (2022)

The role of purinergic receptors in stem cell differentiation
por: Kaebisch, Constanze, et al.
Publicado: (2014)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: von Niederhäusern, Valentin, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation
por: Al-Anazi, Khalid Ahmed
Publicado: (2012)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Follicular Lymphoma
por: Cabrero, Mónica, et al.
Publicado: (2012)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tosi, P., et al.
Publicado: (2012)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015)

Hematopoietic progenitor cell mobilization for autologous transplantation – a literature review
por: Salvino, Marco Aurélio, et al.
Publicado: (2016)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Reactivation of Chagas disease after autologous hematopoietic stem cell transplantation
por: Chalela, Claudia Marcela, et al.
Publicado: (2020)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
por: Jantunen, Esa, et al.
Publicado: (2023)

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
por: Ocio, Enrique M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jlecu4perpq497m7kp5s947lvu